institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Two-Drug GVHD Prophylaxis With Cyclophosphamide Prevails for Stem Cell Transplant

Summary by MedPage Today
(MedPage Today) -- Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclosporin prophylaxis, a randomized trial showed. Median...

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Friday, June 13, 2025.
Sources are mostly out of (0)

Similar News Topics